Clin2
NCT04211259Possibly a fitRecruiting

Loratadine to reduce bone pain during stem cell collection

Plasma Cell Myeloma

Treatments studied

Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.

This early trial studies whether loratadine (an allergy medicine) can reduce bone pain caused by G-CSF, which is used to help your body collect stem cells. If you have multiple myeloma and are preparing for stem cell mobilization, this may make treatment-related bone pain more tolerable.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
70 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You can understand the study and sign an informed consent form
  • You have a confirmed diagnosis of multiple myeloma
  • You can take and keep an oral (by mouth) medicine
  • You speak English well enough to take part in the study
  • You must not be taking allergy medicine or similar study medicines if you’ve had an allergy or strong intolerance
  • You should not be taking aspirin at doses higher than 81 mg within 7 days before starting

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03858205Recruiting
Low-dose radiation to relieve pain from bone tumors

This trial studies whether low-dose radiation can reduce pain from a specific bone lesion caused by multiple myeloma. It may help people whose main problem is painful bone metastasis, with targeted treatment to the painful spot.

Duarte, California
NCT05561387Recruiting· Phase 3
Drug combinations for newly diagnosed myeloma without transplant

This study compares different combinations of medicines for people newly diagnosed with multiple myeloma who cannot safely get a stem cell transplant. It aims to find which drug plan works best and is tolerable for people with “frail” or “intermediate fit” health.

Anchorage, Alaska
NCT07188090Recruiting· Phase 2
Mozobil for stem cell transplant study

This study tests if adding Mozobil (a drug that helps release stem cells) before stem cell transplant can improve outcomes for people with multiple myeloma, Hodgkin's lymphoma, or non-Hodgkin lymphoma. If you are eligible, you will receive Mozobil along with standard stem cell mobilization medicines.

Philadelphia, Pennsylvania
NCT05421416Recruiting· Phase 2
Loratadine to prevent bone pain after stem cell transplant treatment

This trial tests loratadine (an allergy medicine) to see if it can prevent bone pain caused by a growth-factor injection used during lymphoma or multiple myeloma treatment. It may help reduce pain around the time you get that injection and your upcoming stem cell transplant.

Edmonton, Alberta
NCT07300735Recruiting
Can citrus compounds or allergy meds prevent G-CSF bone pain?

This study tests whether taking a combination of two natural compounds (diosmin and hesperidin) similar to those from citrus fruits, or the allergy medicine loratadine, can prevent or reduce bone pain caused by G-CSF injections—a common treatment to boost white blood cells in people with blood cancers.

Alexandria
NCT07101445Recruiting· Phase 4
Comparing steroids to prevent reactions to motixafortide in multiple myeloma

This trial tests two different steroid medicines (methylprednisolone and dexamethasone) to see which works better at preventing side effects from motixafortide, a drug used to help collect stem cells for a stem cell transplant in people with multiple myeloma.

Atlanta, Georgia

Hear when a new Plasma Cell Myeloma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.